TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DXPP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

DXPP

ST13

US500000097877454

Class

42

Filing

97877454

Registration

7770975

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

11/12/2025

Classification

Registered

Trademark type

Word

Nice classes

42

Filing date

04/07/2023

Registration date

04/22/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/22/2025

Last transaction

11/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/24/2023

First use in commerce

02/24/2023

Drawing code

4

Owner type

03

Owner location

Miami, FL

Examiner

RENNIE,GABRIELLE M

Current location

Historical data usage

Holders and representatives

Holders

First Ascent Biomedical Inc.

Representatives

Patricia L. Cotton Pillsbury Winthrop Shaw Pittman LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical drug development services; Providing laboratory research services in the field of gene expression, namely, cancer biology

Publications

History of USPTO decisions and trademark events.

34 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

11/11/2025

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

10/22/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/20/2025

ES7R

TEAS SECTION 7 REQUEST RECEIVED

07/24/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/22/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/02/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/02/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

04/02/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/02/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

04/02/2025

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

04/02/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/13/2024

GNFR

FINAL REFUSAL E-MAILED

12/13/2024

CNFR

SU - FINAL REFUSAL - WRITTEN

12/13/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/14/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/14/2024

ALIE

ASSIGNED TO LIE

11/14/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/05/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/04/2024

GNRT

NON-FINAL ACTION E-MAILED

09/04/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/04/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/18/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/18/2024

IUAF

USE AMENDMENT FILED

06/05/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/05/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2024

PUBO

PUBLISHED FOR OPPOSITION

02/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2024

DOCK

ASSIGNED TO EXAMINER

01/04/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/02/2023

NWAP

NEW APPLICATION ENTERED

04/11/2023

Continuous trademark protection

Get notified about every new filing that threatens DXPP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.